BANDAI NAMCO Entertainment and Crunchyroll Games Announce New Strategic Partnership
27.8.2019 19:00:00 EEST | Business Wire | Press release
Leading interactive entertainment publisher and developer BANDAI NAMCO Entertainment Inc. (hereinafter referred to as BNE) and Crunchyroll Games, LLC (hereinafter referred to as Crunchyroll), today announced a strategic partnership with the goal of providing fans a rewarding and comprehensive experience with their favorite character IPs, through a variety of touchpoints, including animation, games and comics. Crunchyroll is the world’s largest destination for anime and manga, boasting a global community of more than 50 million registered users and over 2 million subscribers. This alliance combines BNE’s expertise on network content development and Crunchyroll’s direct connection to the anime community and robust platform services knowledge, providing a seamless anime and gaming entertainment experience for all.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20190827005199/en/
Cross-Platform IP Experience (Graphic: Business Wire)
As a first step in this partnership, BNE’s browser and mobile game NARUTO X BORUTO NINJA TRIBES will be made available to Crunchyroll users in the U.S. this winter. NARUTO X BORUTO NINJA TRIBES is based on the popular NARUTO and BORUTO anime series, and brings together fan-favorite characters spanning multiple generations of both franchises for one-tap team-based battles. Crunchyroll fans who enjoy the anime series of the same IP on its platform can find and instantly play NARUTO X BORUTO NINJA TRIBES directly from Crunchyroll.com. BNE has plans to launch the game to other territories in the future.
“With Crunchyroll’s expansive global community and subscribers, this partnership was a strategic fit and critical step in expanding our entertainment business,” said Toru Konno, Director, BNE. “We have a corporate philosophy of creating ‘more fun for everyone’ and we are always striving to do that and look forward to seeing what we can build together with Crunchyroll in the coming years.”
“BANDAI NAMCO Entertainment is a global force that shares our goal of connecting the anime community to each other through beloved content,” said Joanne Waage, General Manager, Crunchyroll. “We’re looking forward to building on our partnership to offer even more interactive experiences to bring our fans together.”
For more information on NARUTO X BORUTO NINJA TRIBES , please visit the newly launched game website at https://en-narutoxboruto-tri.bn-ent.net/, or follow the official Facebook page at https://www.facebook.com/ninjatribes/.
About BANDAI NAMCO Entertainment Inc.
BANDAI NAMCO Entertainment Inc. delivers various products and services catering to a worldwide audience in areas such as network content, home video game software and life entertainment based on its IP (Intellectual Property) Axis. BNE gives shape to “a new type of fun” with amazing ideas and newer technology unavailable elsewhere. Furthermore, BNE makes ordinary everyday life more enjoyable and aims to realize “more fun for everyone” that allows customers throughout the world to keep smiling. For more information, please visit https://www.bandainamcoent.co.jp/english/.
About Crunchyroll Games
Crunchyroll Games is a Crunchyroll division focused on the publishing and distribution of anime-inspired interactive content, created to engage with the vibrant gaming enthusiasts across the Crunchyroll community. Crunchyroll is the world’s most popular anime brand, connecting a community of more than 50 million registered users and 2 million subscribers with 360-degree content experiences and the world’s largest collection of anime. Crunchyroll Games titles include “Bungo Stray Dogs: Tales of the Lost,” “Grand Summoners,” “RWBY: Crystal Match,” and the upcoming “Mob Psycho 100: Psychic Battle.” Crunchyroll Games are available across iOS and Android. For more on Crunchyroll Games, please visit crunchyrollgames.com.
*Information in the press release is current as of the announcement date. The contents are subject to change without notice. Please understand in advance.
©2002 MASASHI KISHIMOTO / 2017 BORUTO All Rights Reserved.
©BANDAI NAMCO Entertainment Inc.
All other trademarks are properties of their respective owners.
To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.
View source version on businesswire.com: https://www.businesswire.com/news/home/20190827005199/en/
Contact information
fortyseven communications on behalf of BANDAI NAMCO Entertainment Inc.
Mitch Cavender
mitch@fortyseven.com
Crunchyroll
Bianca Doria
Bdoria@crunchyroll.com
About Business Wire
For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Incyte’s Pivotal frontMIND Trial Showed Tafasitamab (Monjuvi ® /Minjuvi ® ) Combination Significantly Prolonged Progression-free Survival, Reducing the Risk of Disease Progression or Death by 25% in Patients with Previously Untreated, High-risk DLBCL30.5.2026 15:00:00 EEST | Press release
Incyte (Nasdaq:INCY) today announced positive results from the pivotal Phase 3 frontMIND trial evaluating the efficacy and safety of tafasitamab (Monjuvi®/Minjuvi®), a humanized Fc-modified cytolytic CD19-targeting monoclonal antibody, and lenalidomide added to R-CHOP (rituximab, cyclophosphamide, doxorubicin, vincristine and prednisone; Tafa-Len-R-CHOP) versus R-CHOP alone as a first-line treatment for adults with previously untreated diffuse large B-cell lymphoma (DLBCL) or high-grade B-cell lymphoma (HGBL). Eligible patients had an International Prognostic Index (IPI) score of 3-5, or, for patients ≤60 years of age, an age-adjusted IPI (aaIPI) of 2-3. The oral presentation of these data is taking place at the 2026 American Society of Clinical Oncology (ASCO) Annual Meeting being held May 29 – June 2, 2026, in Chicago (Abstract #LBA7000. Session: Oral Abstract Session – Hematologic Malignancies – Lymphoma and Chronic Lymphocytic Leukemia. May 30, 4:00 – 7:00 p.m. ET [3:00 – 6:00 p.m.
Fortegra Completes Acquisition by DB Insurance29.5.2026 23:30:00 EEST | Press release
The Fortegra Group, Inc. ("Fortegra"), a global specialty insurance company, today announced the completion of its acquisition by DB Insurance Co., Ltd. ("DB"), one of Korea's leading property and casualty insurers. The transaction, announced on September 26, 2025, received all required regulatory and stockholder approvals. Fortegra will operate independently, maintaining its existing leadership team, distribution relationships, and underwriting discipline. Agents, distribution partners, and customers will continue to experience the service excellence that has defined the Fortegra experience. Richard Kahlbaugh, Chairman and CEO of Fortegra, said: "Every company eventually changes ownership. That is the nature of business. The closing of this acquisition is a starting point. As part of DB Insurance, Fortegra is positioned to expand our business geographically, enhance our capabilities and deepen our market presence in the US, Europe, the United Kingdom and Asia. Together, DB Insurance a
SINOVAC Receives Nasdaq Notification Regarding Late Filing of 2025 Annual Report29.5.2026 23:01:00 EEST | Press release
Sinovac Biotech Ltd. (Nasdaq: SVA) (“SINOVAC” or the “Company”), a leading provider of biopharmaceutical products in China, today announced that it received a notification letter dated May 20, 2026 (the “Notification Letter”), from Nasdaq Listing Qualifications (“Nasdaq”) stating that as of May 8, 2026, the Company had regained compliance with the periodic filing and interim financial requirements in Nasdaq Listing Rules 5250(c)(1) (the “Periodic Filing Rule”) and 5250(c)(2), as required by the Panel’s decision dated January 21, 2026. As previously disclosed on January 22, 2026, under the Panel’s decision, SINOVAC was required to, on or before May 11, 2026, demonstrate compliance with such Nasdaq Listing Rules by completing filings of its annual report for the year ended December 31, 2024, on Form 20-F and an interim balance sheet and income statement as of the end of its second quarter of 2025 on Form 6-K. The Company timely completed such filings as required by the Panel’s decision.
From Network Automation to Agentic NetOps: NetBrain Sets the Standard for Deploying AI in Network Operations29.5.2026 16:00:00 EEST | Press release
NetBrain Technologies, Inc. today announced major new platform features that advance Agentic NetOps from an emerging category to operational reality. NetBrain's clients are already deploying agents that are diagnosing and remediating issues across complex multi-vendor enterprise networks. These new features further extend the platform with new agent tooling, cross-domain context, and open interfaces for the broader agentic enterprise. Early customer outcomes show the magnitude of the shift: A leading health insurer used NetBrain's Deep Diagnosis agent to diagnose and resolve a weeks old VPN connectivity issue in under five minutes. A large manufacturer resolved a critical device issue with a single prompt, isolating the root cause across the network path in under 20 minutes, saving hundreds of hours of engineer time, shrinking MTTR by more than 95%. A global telecommunications firm found NetBrain's context-grounded agents outperformed a stand-alone frontier LLM on a persistent firewall
Adtran resolves long-running patent litigation, reinforcing commitment to defend innovation29.5.2026 15:00:00 EEST | Press release
Adtran today announced it has resolved a patent litigation matter, resulting in a full settlement and dismissal of all claims with prejudice. The case, initiated in 2020 by a non-practicing entity asserting five patents, was transferred to the US District Court for the Northern District of Alabama in 2021 following a successful motion by Adtran. Adtran subsequently filed counterclaims, including bad-faith patent assertion under Alabama statutory law. The settlement includes payment to Adtran to resolve its counterclaims. Terms of the agreement remain confidential. “This outcome reflects a disciplined and consistent approach to protecting our innovation and our customers,” said Justin Ferguson, SVP and general counsel at Adtran. “We take all claims seriously, but we will not hesitate to defend ourselves when assertions lack merit. Situations like this place unnecessary strain on technology providers and divert resources from advancing networks and services. By advancing our counterclaim
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom